These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 785150)

  • 21. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke.
    Dekoninck WJ; Jocquet P; Jacquy J; Henriet M
    Arzneimittelforschung; 1978; 28(9):1654-7. PubMed ID: 383107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
    Lanfranchi M; Magnani G; Sinforiani E; Casali R
    Int J Clin Pharmacol Res; 1984; 4(4):307-12. PubMed ID: 6389380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
    Linquette M
    Lille Med; 1978 May; 23(5 Suppl 1):379-81. PubMed ID: 682847
    [No Abstract]   [Full Text] [Related]  

  • 25. [Double-blind controlled study of the effects of vincamine hydrochloride on some parameters of cardiovascular function in aged bronchopneumopathic patients].
    Mazzola C; Della Torre F; Izzo M; Colombo Pirola L
    Clin Ter; 1979 Dec; 91(5):485-503. PubMed ID: 397034
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative study of the effect of Devincan and Stugeron in patients suffering from cerebrovascular diseases treated at medical departments.
    Udvarhelyi A
    Ther Hung; 1978; 26(1):29-32. PubMed ID: 663872
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental clinical studies on the effect of eburnamonine in cerebrovascular disorders.
    Jansen W; O'Connolly M; Lehmann E; Mayer M
    Pharmacopsychiatry; 1986 Sep; 19(5):389-94. PubMed ID: 3534902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
    Ambrozi L; Bruck J; Tschabitscher H
    Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects].
    Schenker H
    Med Klin; 1979 Oct; Suppl():48-50. PubMed ID: 542168
    [No Abstract]   [Full Text] [Related]  

  • 31. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
    Burtsev EM; Shprakh VV; Savkov VS
    Ross Med Zh; 1992; (2):41-3. PubMed ID: 1643337
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of cerebrovascular insufficiency. A double blind trial of Cetal retard against cinnarizine (author's transl)].
    Bartels H
    MMW Munch Med Wochenschr; 1977 Oct; 119(43):1407-10. PubMed ID: 412079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Trial of using Cavinton in cerebrovascular disorders].
    Shtok VN; Eremeeva SV
    Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and experimental evaluation of the use of eburnamonine in acute anc chronic cerebro-vascular insufficiency].
    Rampello L; Barbagallo G; Costanzo E; Sciacca A; Russo S
    Clin Ter; 1981 Feb; 96(4):371-81. PubMed ID: 7214860
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vincamine in the treatment of cerebral circulatory insufficiency in old age].
    Turrisi E; D'Alise R; Mea A; Vitagliano A
    Minerva Cardioangiol; 1975 Jan; 23(1):20-32. PubMed ID: 1143645
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
    Lebedeva NV; Khrapova EV
    Sov Med; 1990; (1):60-3. PubMed ID: 2190329
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P
    Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Trial of a new therapeutic agent, Pervincamine, in the post-concussion syndrome of patients with head injuries. Application of a double-blind control system and sequential analysis].
    Van Laere E; De Mol J
    Acta Psychiatr Belg; 1975 Mar; 75(2):190-20. PubMed ID: 788465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man].
    Bernini FP; Smaltino F
    Acta Neurol (Napoli); 1974 Mar; 29(2):170-84. PubMed ID: 4849693
    [No Abstract]   [Full Text] [Related]  

  • 40. [Polymorphic effects of cavinton: experimental and clinical evidence].
    Kasatkin DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9 Pt 2):8-12. PubMed ID: 21465683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.